Right, but recall in the PF the CMA said that none of the behavioral remedies they've seen would be acceptable for them but that they would consider others as presented to them.
"First, Microsoft's commercial strategy to date suggests that there are strategic benefits in limiting the availability of acquired gaming content. Microsoft has acquired a range of gaming studios over the past few years and, with very few exceptions, has made their future releases of games exclusive or redirected the efforts of those studios to produce exclusive Xbox games. Although we recognise that Activision is a bigger studio than any acquired by Microsoft before, this pattern of behaviour seems to be consistent with Microsoft's commercial strategy."
"7. During our investigation, Microsoft told us that it has offered to enter into new long-term agreements with SIE, Nintendo, and Steam to supply them with CoD post-Merger. Whether some form of supply or licensing agreement might satisfactorily remedy our concerns in gaming consoles is something that we will consider as part of our remedies process, rather than in our competitive assessment."
"At this stage, the CMA considers that certain divestitures and/or prohibition are, in principle, feasible remedies in this case. The provisional SLCs are not time-limited, and while RCBs have not yet been assessed in detail, evidence on efficiencies received to date does not suggest that RCBs might be substantial."
"As noted above, the circumstances in which the CMA might select a behavioural remedy as the primary source of remedial action are not present in this case. The two markets in which the CMA has provisionally found SLCs are multi-faceted and continue to develop. This is particularly the case in cloud gaming, where the customer offerings and business models of market participants are evolving rapidly. We are of the initial view that any behavioural remedy in this case is likely to present material effectiveness 14 Merger Remedies: CMA87 (December 2018), paragraph 7.4. 15 Merger Remedies: CMA87 (December 2018), paragraph 7.3. 10 risks. We invite the Parties to provide evidence on how these risks could be appropriately managed to ensure that any behavioural remedy is effective."